Document Detail


Hyperechogenic fetal bowel: a large French collaborative study of 682 cases.
MedLine Citation:
PMID:  12923859     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Hyperechogenic fetal bowel is detected in 0.1-1.8% of pregnancies during the second or third trimester. This ultrasound sign is associated with cystic fibrosis or other conditions (e.g., chromosomal anomalies, viral infection) but no large-scale prospective studies have been conducted. This 1997-1998 multicenter study in 22 molecular biology laboratories identified 682 cases of hyperechogenic fetal bowel detected by routine ultrasound examination during the second (86%) or third trimester. The fetal bowel was considered hyperechogenic when its echogenicity was broadly similar to, or greater than, that of the surrounding bone. Karyotyping, screening for viral infection, and screening for cystic fibrosis mutations were performed in all cases. Pregnancy outcome and postnatal follow-up were obtained in 656 of the 682 cases (91%). In 447 cases (65.5%), a normal birth was observed. Multiple malformations were observed in 47 cases (6.9%), a significant chromosomal anomaly was noted in 24 (3.5%), cystic fibrosis in 20 (3%), and viral infection in 19 (2.8%). In utero unexplained fetal death occurred in 1.9% of cases, toxemia in 1.2%, IUGR in 4.1%, and premature birth in 6.2%. This study demonstrates that this ultrasound sign is potentially associated with medically significant outcomes. Having established that the bowel is hyperechogenic, recommended investigations should include a detailed scan with Doppler measurements, fetal karyotyping, cystic fibrosis screening, and infectious disease screening. After birth, newborns require pediatric examination because a surgical treatment may be necessary. This should be combined with clear counseling of the parents.
Authors:
B Simon-Bouy; V Satre; C Ferec; M C Malinge; E Girodon; E Denamur; N Leporrier; P Lewin; F Forestier; F Muller;
Related Documents :
24253049 - Long-term disruption of maternal glucose homeostasis induced by prenatal glucocorticoid...
15912479 - Screening for down syndrome based on maternal age or fetal nuchal translucency: a rando...
10392049 - Screening for disease in pregnancy.
14562949 - Maternal carriage and antimicrobial resistance profile of group b streptococcus.
19626619 - The proform of eosinophil major basic protein: a new maternal serum marker for adverse ...
18303499 - The use of prenatal ultrasound for the detection of fetal aneuploidy.
17185789 - Infertility in polycystic ovary syndrome: focus on low-dose gonadotropin treatment.
17674259 - Dynamic cervical length changes: preliminary observations from 30-minute transvaginal u...
23200099 - A case-control study of placental lesions associated with pre-eclampsia.
Publication Detail:
Type:  Journal Article; Multicenter Study    
Journal Detail:
Title:  American journal of medical genetics. Part A     Volume:  121A     ISSN:  1552-4825     ISO Abbreviation:  Am. J. Med. Genet. A     Publication Date:  2003 Sep 
Date Detail:
Created Date:  2003-08-18     Completed Date:  2003-12-12     Revised Date:  2008-05-21    
Medline Journal Info:
Nlm Unique ID:  101235741     Medline TA:  Am J Med Genet A     Country:  United States    
Other Details:
Languages:  eng     Pagination:  209-13     Citation Subset:  IM    
Copyright Information:
Copyright 2003 Wiley-Liss, Inc.
Affiliation:
SESEP, Université de Versailles, Versailles, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chromosome Aberrations
Cystic Fibrosis / diagnosis,  genetics
Cystic Fibrosis Transmembrane Conductance Regulator / genetics
Female
Fetal Diseases / ultrasonography*
Fetal Growth Retardation
Gastrointestinal Diseases / ultrasonography*
Gastrointestinal Tract / abnormalities*,  embryology*,  ultrasonography
Humans
Infant, Newborn
Karyotyping
Phenotype
Predictive Value of Tests
Pregnancy
Pregnancy Outcome
Pregnancy Trimester, Second
Prognosis
Prospective Studies
Risk Factors
Ultrasonography, Prenatal*
Chemical
Reg. No./Substance:
0/CFTR protein, human; 126880-72-6/Cystic Fibrosis Transmembrane Conductance Regulator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Double heterozygosity in bone growth disorders: four new observations and review.
Next Document:  Utilization of genetic counseling by parents of a child or fetus with congenital malformation in Nor...